Mischke R
Klinik für kleine Haustiere, Tierärztlichen Hochschule Hannover.
Berl Munch Tierarztl Wochenschr. 1997 Dec;110(11-12):445-50.
The study enclosed 30 dogs with severe or end stage chronic renal failure showing distinctly increased concentrations of urea and creatinine. In most of the 15 cases, where a pathologic-histological investigation of the kidney was carried out, a glomerulonephritis was observed (n = 11), partly accompanied by an interstitial nephritis or tubulonephrosis, respectively. Compared to the control group (n > or = 100) the most significant changes were the distinctly increased concentrations of fibrinogen (6.22 [2.95-11.83] g/l; median [minimum-maximum]) and activity of the coagulation factors V (median = 165%), VII (198%), X (176%), VIII:C (154%), and IX (178%) as well as of protein C (147%) (each: p < 0,0001 [Mann-Whitney-Test]). Thereby, the latter does not contribute to hypercoagulability in dogs with chronic renal insufficiency. The activity of antithrombin III was clearly diminished (69[41-112]%), and was closely correlated to the albumin concentration (r = 0.7000; p = 0.001) reflecting the joint renal loss of these proteins of nearly a size. Surprisingly a reagent dependent prolongation of the activated partial thromboplastin time appeared. Against that, a corresponding diminution of the activity of single coagulation factors was demonstrated only seldom, reaching only a small degree, and related almost exclusively to the contact activating system. Compared to the respecting reference range the concentrations of soluble fibrin or fibrin degradation products were increased in 15 or 21 (of 29) samples, and were, thereby, significantly higher than in the control group (p < 0.0001). This reflects the enhanced intravascular coagulation occurring possibly limited to the region of the renal alteration that should be more noticed in therapy.
该研究纳入了30只患有严重或终末期慢性肾衰竭且尿素和肌酐浓度明显升高的犬。在对其中15只犬进行肾脏病理组织学检查的大多数病例中,观察到肾小球肾炎(n = 11),部分病例分别伴有间质性肾炎或肾小管肾炎。与对照组(n≥100)相比,最显著的变化是纤维蛋白原浓度明显升高(6.22 [2.95 - 11.83] g/l;中位数[最小值 - 最大值])以及凝血因子V(中位数 = 165%)、VII(198%)、X(176%)、VIII:C(154%)、IX(178%)和蛋白C(147%)的活性升高(每项:p < 0.0001 [曼 - 惠特尼检验])。因此,后者对慢性肾功能不全犬的高凝状态无影响。抗凝血酶III的活性明显降低(69[41 - 112]%),且与白蛋白浓度密切相关(r = 0.7000;p = 0.001),反映了这些蛋白质在肾脏中几乎等量的共同丢失。令人惊讶的是,出现了依赖试剂的活化部分凝血活酶时间延长。与之相反,单个凝血因子活性的相应降低很少见,程度也很小,且几乎仅与接触激活系统有关。与相应的参考范围相比,29份样本中有15份或21份样本的可溶性纤维蛋白或纤维蛋白降解产物浓度升高,因此明显高于对照组(p < 0.0001)。这反映了可能仅限于肾脏病变区域的血管内凝血增强,在治疗中应更予以关注。